11.05.10
Valeant Pharmaceuticals' subsidiary, Biovail Laboratories, is taking over several privately-owned pharmacy skin care brands in Australia. The brands—including well-established local brands such as Hamilton's Suncare and Hamilton's Skin Therapy—are ranked No.2 in sun care in the Australian pharmacy market, according to Valeant.
"These leading skin care brands nicely augment Valeant's current suncare product portfolio and expands our presence in the pharmacy over-the-counter (OTC) market," state J. Michael Pearson, chief executive officer. "The brands we acquired through our previous transactions have continued to perform well and the addition of a key brand such as Hamilton Sunscreen will enhance our portfolio and offer synergies to our growing pharmacy OTC platform."
"These leading skin care brands nicely augment Valeant's current suncare product portfolio and expands our presence in the pharmacy over-the-counter (OTC) market," state J. Michael Pearson, chief executive officer. "The brands we acquired through our previous transactions have continued to perform well and the addition of a key brand such as Hamilton Sunscreen will enhance our portfolio and offer synergies to our growing pharmacy OTC platform."
In 2009, Valeant acquired Private Formula International, a leading skin care company in Australia and New Zealand and obtained global rights to Dr. LeWinn's Private Formula, a premium skin care line; Hissyfit, an anti-aging skin care line; and Revitanail/Renunail, a line of nail strengtheners. Valeant also acquired a number of skin care products under the Reef brand that are local to Australia. The company’s consumer and OTC brands also include Dermaglow, Dr. Renaud,Kinerase and CeraVe.